An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy
- PMID: 25935330
- DOI: 10.1007/s00345-015-1571-y
An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy
Abstract
Purpose: To evaluate the benefit of an antimicrobial prophylaxis protocol using rectal swab cultures in patients undergoing transrectal ultrasound (TRUS)-guided prostate biopsy in our Veterans Affairs population.
Methods: Between June 1, 2013, and June 1, 2014, we implemented an antimicrobial prophylaxis protocol using rectal swab cultures on selective media containing ciprofloxacin for all men scheduled for TRUS-guided prostate biopsy. Data from 2759 patients from Jan 1, 2006 to May 31, 2013, before protocol implementation served as historical controls. Patients with fluoroquinolone (FQ)-susceptible organisms received FQ monotherapy, while those with FQ-resistant organisms received targeted prophylaxis. Our objective was to compare the rate of infectious complications 30 days after prostate biopsy before and after implementation of our antimicrobial protocol.
Results: One hundred and sixty-seven patients received rectal swab cultures using our protocol. Seventeen (14 %) patients had FQ-resistant positive cultures. Patients with positive FQ-resistant culture results were more likely to have had a history of previous prostate biopsy and a positive urine culture in the last 12 months (p = 0.032, p = 0.018, respectively). The average annual infectious complication rate within 30 days of biopsy was reduced from 2.8 to 0.6 % before and after implementation of our antimicrobial prophylaxis protocol using rectal swab cultures, although this difference was not statistically significant (p = 0.13).
Conclusion: An antimicrobial prophylaxis protocol using rectal culture swabs is a viable option for prevention of TRUS-guided prostate biopsy infectious complications. After implementation of an antimicrobial prophylaxis protocol, we observed a nonsignificant decrease in the rate of post-biopsy infectious complications when compared to historical controls.
Keywords: Antibiotic prophylaxis/methods; Biopsy/methods; Postoperative complications/prevention and control; Prostate/pathology; Prostate/ultrasonography; Rectum/microbiology.
Similar articles
-
Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care.J Urol. 2012 Apr;187(4):1275-9. doi: 10.1016/j.juro.2011.11.115. Epub 2012 Feb 16. J Urol. 2012. PMID: 22341272
-
"Targeted" prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy.Investig Clin Urol. 2017 Sep;58(5):365-370. doi: 10.4111/icu.2017.58.5.365. Epub 2017 Aug 8. Investig Clin Urol. 2017. PMID: 28868509 Free PMC article.
-
Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.BJU Int. 2013 May;111(6):946-53. doi: 10.1111/j.1464-410X.2012.11637.x. Epub 2013 Mar 6. BJU Int. 2013. PMID: 23464844 Clinical Trial.
-
Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: A bias-adjusted meta-analysis.Int J Antimicrob Agents. 2014 Apr;43(4):301-9. doi: 10.1016/j.ijantimicag.2014.01.008. Epub 2014 Feb 9. Int J Antimicrob Agents. 2014. PMID: 24630305 Review.
-
Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis.World J Urol. 2018 Mar;36(3):323-330. doi: 10.1007/s00345-017-2163-9. Epub 2017 Dec 29. World J Urol. 2018. PMID: 29288398 Review.
Cited by
-
The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis.World J Urol. 2018 Jul;36(7):1007-1017. doi: 10.1007/s00345-018-2217-7. Epub 2018 Feb 16. World J Urol. 2018. PMID: 29453690
-
Reducing Infectious Complications Following Transrectal Ultrasound-guided Prostate Biopsy: A Systematic Review.Rev Urol. 2016;18(2):73-89. doi: 10.3909/riu0713. Rev Urol. 2016. PMID: 27601966 Free PMC article.
-
A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy.Ann Afr Med. 2019 Jul-Sep;18(3):132-137. doi: 10.4103/aam.aam_48_18. Ann Afr Med. 2019. PMID: 31417013 Free PMC article. Clinical Trial.
-
Chemoprophylaxis during transrectal prostate needle biopsy: critical analysis through randomized clinical trial.World J Urol. 2018 Nov;36(11):1845-1852. doi: 10.1007/s00345-018-2319-2. Epub 2018 May 7. World J Urol. 2018. PMID: 29736609 Clinical Trial.
-
Antimicrobial prophylaxis protocol based on rectal swab culture before prostate biopsy to prevent infectious complications: a prospective randomized comparative study.Int Urol Nephrol. 2024 Aug;56(8):2495-2502. doi: 10.1007/s11255-024-03998-7. Epub 2024 Mar 7. Int Urol Nephrol. 2024. PMID: 38448785 Clinical Trial.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical